Quinine Sulfate Global Market Report 2026

Quinine sulfate is a naturally sourced alkaloid drug obtained from the bark of the cinchona tree and is widely used in pharmaceutical formulations for its medicinal benefits. It is mainly utilized in the treatment of malaria and in the relief of nocturnal leg cramps, as it works by disrupting the reproduction of malaria-causing parasites and reducing involuntary muscle contractions.

The primary types of quinine sulfate include 200 mg, 300 mg, and other dosages. A 200 mg quinine sulfate dosage refers to the amount of medication administered to treat conditions such as malaria, with each dose containing 200 milligrams of the active compound. Available product forms include quinine sulfate tablets, capsules, injections, powder, and oral solutions. These products are distributed through multiple channels, including hospitals, retail pharmacies, and online pharmacies. Quinine sulfate is used for applications such as the treatment of malaria, troublesome leg cramps, lupus, rheumatoid arthritis, and other conditions. The end users of quinine sulfate consist of adults, pediatric patients, and geriatric populations.

Tariffs have affected the quinine sulfate market by increasing the cost of imported cinchona bark, extraction agents, and processing chemicals used in drug production. These impacts are most pronounced in Africa and parts of Asia where dependence on cross border raw material sourcing remains high. Rising tariff related costs have contributed to higher manufacturing expenses and pressure on pricing for antimalarial therapies. This has influenced procurement decisions for public health programs and hospital supply chains. However, tariffs are also promoting regional sourcing strategies, local pharmaceutical manufacturing, and improved supply resilience over the long term.

The quinine sulfate market research report is one of a series of new reports from The Business Research Company that provides quinine sulfate market statistics, including quinine sulfate industry global market size, regional shares, competitors with a quinine sulfate market share, detailed quinine sulfate market segments, market trends and opportunities, and any further data you may need to thrive in the quinine sulfate industry. This quinine sulfate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quinine sulfate market size has grown strongly in recent years. It will grow from $2.59 billion in 2025 to $2.8 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to high prevalence of malaria in endemic regions, long-standing clinical use of quinine, limited alternative therapies in low-income regions, inclusion in essential medicines lists, established extraction methods.

The quinine sulfate market size is expected to see strong growth in the next few years. It will grow to $3.81 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to ongoing malaria control programs, demand for low-cost antimalarials, expansion of generic manufacturing, improved drug delivery formats, rising healthcare access in developing regions. Major trends in the forecast period include sustained demand for antimalarial therapies, continued use in nocturnal leg cramp treatment, expansion of generic quinine products, growing focus on affordable essential medicines, improved pharmaceutical formulations.

The increasing incidence of malaria is expected to drive the growth of the quinine sulfate market in the coming years. Malaria is a life-threatening infectious disease caused by Plasmodium parasites and transmitted through the bites of infected female Anopheles mosquitoes. The rise in malaria cases is attributed to the expansion of mosquito habitats due to climate change, the emergence of drug-resistant parasite strains, and persistent gaps in access to healthcare services. The quinine sulfate market plays a key role in malaria treatment by eliminating Plasmodium parasites and preventing their growth and reproduction within red blood cells. For example, in December 2024, the UK Health Security Agency (UKHSA), a UK-based government department, reported in its annual malaria report for 2023 that 2,106 cases of imported malaria were recorded in the UK, representing a 26% increase compared to 2022. Therefore, the rising incidence of malaria is contributing to the growth of the quinine sulfate market.

The growing interest in natural and organic products is anticipated to drive the expansion of the quinine sulfate market in the coming years. Natural and organic products are defined as goods produced using minimally processed, plant-based, or sustainably sourced ingredients, free from synthetic chemicals and artificial additives. This rising interest is fueled by increasing health consciousness, a preference for chemical-free alternatives, and a stronger emphasis on environmentally responsible and ethical sourcing practices. The quinine sulfate market aligns with this trend by providing a plant-derived compound extracted from cinchona bark, which matches consumer demand for traditional herbal ingredients used in wellness and medicinal applications. For example, in May 2024, according to the 2024 Organic Industry Survey released by the Organic Trade Association (OTA), a US-based business association, U.S. certified organic product sales totaled $69.7 billion in 2023, marking a 3.4% increase compared to 2022. Thus, the rising interest in natural and organic products is contributing to the growth of the quinine sulfate market.

In June 2023, AlphaTalents Africa LP, an investment firm based in Africa, acquired a controlling interest in Pharmakina for an undisclosed sum. Through this acquisition, AlphaTalents Africa LP seeks to enhance local quinine processing capabilities and increase the production of cost-effective anti-malarial medicines in the Democratic Republic of Congo. Pharmakina SA is an Africa-based company that manufactures and supplies quinine sulfate.

Major companies operating in the quinine sulfate market are Sanofi SA, Viatris Inc., Teva Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla Limited, Lupin Limited, Strides Pharma, Wockhardt Ltd., Pharmakina SA, Alchem International Private Limited, SimSon Pharma Limited, Hangzhou Dayang Co. Ltd., Haihang Industry Co. Ltd., Aecochem Corp, Buchler GmbH, Prism Industries Private Limited, Shreeji Pharma International, Sihauli Chemicals Private Limited

Asia-Pacific was the largest region in the quinine sulfate market in 2025. The regions covered in the quinine sulfate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the quinine sulfate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quinine sulfate market consists of sales of quinine sulfate suspensions, quinine sulfate granules, quinine sulfate infusions, quinine sulfate suppositories, and quinine sulfate topical preparations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Quinine Sulfate Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses quinine sulfate market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quinine sulfate ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The quinine sulfate market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: 200mg; 300mg; Other Types
• 2) By Product Form: Quinine Sulfate Tablets; Quinine Sulfate Capsules; Quinine Sulfate Injections; Quinine Sulfate Powder; Quinine Sulfate Oral Solutions
• 3) By Distribution Channel: Hospitals; Retail Pharmacies; Online Pharmacies
• 4) By Application: Malaria; Problematic Leg Cramps; Lupus; Rheumatoid Arthritis; Other Applications
• 5) By End-User: Adults; Pediatrics; Geriatrics
• Companies Mentioned: Sanofi SA; Viatris Inc.; Teva Pharmaceuticals; Sun Pharmaceutical Industries Ltd.; Aurobindo Pharma; Dr. Reddy's Laboratories; Cipla Limited; Lupin Limited; Strides Pharma; Wockhardt Ltd.; Pharmakina SA; Alchem International Private Limited; SimSon Pharma Limited; Hangzhou Dayang Co. Ltd.; Haihang Industry Co. Ltd.; Aecochem Corp; Buchler GmbH; Prism Industries Private Limited; Shreeji Pharma International; Sihauli Chemicals Private Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.